1024 - ROR1-Signaling Enhances Survival and Drug-Resistance of del(17p)/TP53-Mutated CLL by Mitigating Oxidative Stress Via Activation of NRF2

Primary Author / Presenter(s)

CH

Can Huang, PhD

UC San Diego
La Jolla, California, United States
Michael Y. Choi, MD

UC San Diego
La Jolla, California, United States
GW

George F. Widhopf II, PhD

UC San Diego
La Jolla, California, United States
Thomas J. Kipps, MD, PhD

Distinguished Professor of Medicine, Co-Director, Hematology Malignancy Program; Director, Center for Novel Therapies; Evelyn and Edwin Tasch Chair in Cancer Research
UC San Diego, Moores Cancer Center
San Diego, California, United States